Public health authorities and major medical organizations continue to recommend updated COVID-19 vaccines for targeted populations, particularly older adults, immunocompromised individuals, and those with underlying medical conditions, rather than having discontinued them entirely. However, messaging and policy shifts reflect a transition from emergency pandemic-era universal mandates toward a targeted, seasonal immunization strategy similar to the annual influenza shot. This evolution accounts for widespread population immunity, viral evolution, and a focus on preventing severe disease, hospitalization, and death in high-risk groups rather than achieving complete transmission blockades.